Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...
What is the outlook for someone who has squamous cell carcinoma of the skin? The outlook is excellent when found early and properly treated. More than 90% of patients are cured. FDA-approved ...
Skin malignancies are the most common cancers in the United States. 1 Typically, skin cancer is categorized as either melanoma or nonmelanoma skin cancer, which is also known as keratinocyte ...
A new clinical trial at HonorHealth Research Institute shows promise for treating advanced cutaneous squamous cell carcinoma using a targeted immune therapy. A patient with cutaneous squamous cell ...
There are nearly 40,000 U.S. cases of cutaneous squamous cell carcinoma each year that advance to stages that are difficult to treat and life-threatening The investigational drug is an engineered ...
In patients with an advanced type of skin cancer called cutaneous squamous cell carcinoma (cSCC), those who received the combination of the immunotherapy drug avelumab and targeted agent cetuximab had ...
MSK radiation oncologist Dr. Nancy Lee helped design the clinical trial showing that immunotherapy given around surgery could reduce recurrence of some head and neck cancers. A phase 3 clinical trial ...
SAN MATEO, Calif.--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines, today announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback